Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin | Patent Number 08853231

US 08853231 B2
Application Number13679602
Publication NumberUS 20130289269 A1
Pendency1 year, 10 months, 25 days
Filled DateNov 16, 2012
Priority DateNov 4, 2004
Publication DateOct 31, 2013
Expiration DateNov 4, 2024
Inventor/ApplicantsManuela Campana
Dario Braga
Donatella Confortini
Paolo Righi
Vincenzo Cannata
Giuseppe Claudio Viscomi
Goffredo Rosini
ExaminesKIFLE, BRUCK
Art Unit1622
Technology Center1600
Assignments
Alfa Wassermann S.p.a.
Current
Alfa Wassermann S.p.a.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.